Cargando…

Psychiatric comorbidities in patients with major depressive disorder

BACKGROUND: Psychiatric comorbidities are common in major depressive disorder (MDD). They may worsen outcome and cause economic burden. The primary objective was to examine the prevalence of psychiatric comorbidities in MDD. The secondary objectives were to compare the presence of comorbidities betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Thaipisuttikul, Papan, Ittasakul, Pichai, Waleeprakhon, Punjaporn, Wisajun, Pattarabhorn, Jullagate, Sudawan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235207/
https://www.ncbi.nlm.nih.gov/pubmed/25419132
http://dx.doi.org/10.2147/NDT.S72026
_version_ 1782344987572174848
author Thaipisuttikul, Papan
Ittasakul, Pichai
Waleeprakhon, Punjaporn
Wisajun, Pattarabhorn
Jullagate, Sudawan
author_facet Thaipisuttikul, Papan
Ittasakul, Pichai
Waleeprakhon, Punjaporn
Wisajun, Pattarabhorn
Jullagate, Sudawan
author_sort Thaipisuttikul, Papan
collection PubMed
description BACKGROUND: Psychiatric comorbidities are common in major depressive disorder (MDD). They may worsen outcome and cause economic burden. The primary objective was to examine the prevalence of psychiatric comorbidities in MDD. The secondary objectives were to compare the presence of comorbidities between currently active and past MDD, and between patients with and without suicidal risk. METHODS: This was a cross-sectional study. A total of 250 patients with lifetime MDD and age ≥18 years were enrolled. The Mini International Neuropsychiatric Interview (MINI), Thai version, was used to confirm MDD diagnosis and classify comorbidities. MDD diagnosis was confirmed in 190, and 60 patients were excluded due to diagnosis of bipolar disorder. RESULTS: Of the 190 MDD patients, 25.8% had current MDD and 74.2% had past MDD. Eighty percent were women. The mean age at enrollment was 50 years, and at MDD onset was 41 years. Most patients were married (53.2%), employed (54.8%), and had ≥12 years of education (66.9%). There were 67 patients (35.3%) with one or more psychiatric comorbidities. Comorbidities included dysthymia (19.5%), any anxiety disorders (21.1%) (panic disorder [6.8%], agoraphobia [5.8%], social phobia [3.7%], obsessive–compulsive disorder [OCD] [4.7%], generalized anxiety disorder [5.3%], and post-traumatic stress disorder [4.2%]), alcohol dependence (0.5%), psychotic disorder (1.6%), antisocial personality (1.1%), and eating disorders (0%). Compared with past MDD, the current MDD group had significantly higher OCD (P<0.001), psychotic disorder (P=0.048), past panic disorder (P=0.017), and suicidal risk (P<0.001). Suicidal risk was found in 32.1% of patients. Patients with suicidal risk had more comorbid anxiety disorder of any type (P=0.019) and psychotic disorder (P=0.032). CONCLUSION: Several comorbidities were associated with MDD. Patients with active MDD had higher comorbid OCD, psychotic disorder, past panic disorder, and suicidal risk. Patients with suicide risk had higher comorbid anxiety and psychotic disorders.
format Online
Article
Text
id pubmed-4235207
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42352072014-11-21 Psychiatric comorbidities in patients with major depressive disorder Thaipisuttikul, Papan Ittasakul, Pichai Waleeprakhon, Punjaporn Wisajun, Pattarabhorn Jullagate, Sudawan Neuropsychiatr Dis Treat Original Research BACKGROUND: Psychiatric comorbidities are common in major depressive disorder (MDD). They may worsen outcome and cause economic burden. The primary objective was to examine the prevalence of psychiatric comorbidities in MDD. The secondary objectives were to compare the presence of comorbidities between currently active and past MDD, and between patients with and without suicidal risk. METHODS: This was a cross-sectional study. A total of 250 patients with lifetime MDD and age ≥18 years were enrolled. The Mini International Neuropsychiatric Interview (MINI), Thai version, was used to confirm MDD diagnosis and classify comorbidities. MDD diagnosis was confirmed in 190, and 60 patients were excluded due to diagnosis of bipolar disorder. RESULTS: Of the 190 MDD patients, 25.8% had current MDD and 74.2% had past MDD. Eighty percent were women. The mean age at enrollment was 50 years, and at MDD onset was 41 years. Most patients were married (53.2%), employed (54.8%), and had ≥12 years of education (66.9%). There were 67 patients (35.3%) with one or more psychiatric comorbidities. Comorbidities included dysthymia (19.5%), any anxiety disorders (21.1%) (panic disorder [6.8%], agoraphobia [5.8%], social phobia [3.7%], obsessive–compulsive disorder [OCD] [4.7%], generalized anxiety disorder [5.3%], and post-traumatic stress disorder [4.2%]), alcohol dependence (0.5%), psychotic disorder (1.6%), antisocial personality (1.1%), and eating disorders (0%). Compared with past MDD, the current MDD group had significantly higher OCD (P<0.001), psychotic disorder (P=0.048), past panic disorder (P=0.017), and suicidal risk (P<0.001). Suicidal risk was found in 32.1% of patients. Patients with suicidal risk had more comorbid anxiety disorder of any type (P=0.019) and psychotic disorder (P=0.032). CONCLUSION: Several comorbidities were associated with MDD. Patients with active MDD had higher comorbid OCD, psychotic disorder, past panic disorder, and suicidal risk. Patients with suicide risk had higher comorbid anxiety and psychotic disorders. Dove Medical Press 2014-11-10 /pmc/articles/PMC4235207/ /pubmed/25419132 http://dx.doi.org/10.2147/NDT.S72026 Text en © 2014 Thaipisuttikul et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Thaipisuttikul, Papan
Ittasakul, Pichai
Waleeprakhon, Punjaporn
Wisajun, Pattarabhorn
Jullagate, Sudawan
Psychiatric comorbidities in patients with major depressive disorder
title Psychiatric comorbidities in patients with major depressive disorder
title_full Psychiatric comorbidities in patients with major depressive disorder
title_fullStr Psychiatric comorbidities in patients with major depressive disorder
title_full_unstemmed Psychiatric comorbidities in patients with major depressive disorder
title_short Psychiatric comorbidities in patients with major depressive disorder
title_sort psychiatric comorbidities in patients with major depressive disorder
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235207/
https://www.ncbi.nlm.nih.gov/pubmed/25419132
http://dx.doi.org/10.2147/NDT.S72026
work_keys_str_mv AT thaipisuttikulpapan psychiatriccomorbiditiesinpatientswithmajordepressivedisorder
AT ittasakulpichai psychiatriccomorbiditiesinpatientswithmajordepressivedisorder
AT waleeprakhonpunjaporn psychiatriccomorbiditiesinpatientswithmajordepressivedisorder
AT wisajunpattarabhorn psychiatriccomorbiditiesinpatientswithmajordepressivedisorder
AT jullagatesudawan psychiatriccomorbiditiesinpatientswithmajordepressivedisorder